Qlife Holding AB (SE:QLIFE)
:QLIFE
Want to see SE:QLIFE full AI Analyst Report?
QLIFE Stock Chart & Stats
kr3.01
-kr0.24(-7.59%)
At close: 4:00 PM EST
kr3.01
-kr0.24(-7.59%)
Day’s Range― - ―
52-Week Rangekr1.20 - kr5.70
Previous CloseN/A
Volume24.68K
Average Volume (3M)97.19K
Market Cap
kr57.75M
Enterprise Valuekr26.82M
Total Cash (Recent Filing)kr6.63M
Total Debt (Recent Filing)kr8.71M
Price to Earnings (P/E)―
Beta1.55
Next Earnings
Aug 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.27
Shares Outstanding28,874,178
10 Day Avg. Volume81,486
30 Day Avg. Volume97,188
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-4.74
Price to Sales (P/S)109.73
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-126.16
Revenue Forecast (FY)kr116.00M
Bulls Say, Bears Say
Bulls Say
Proprietary Platform For Near‑patient DiagnosticsQlife's core offering is an integrated platform of instruments, assays and software for rapid, near‑patient molecular testing. That platform-based approach creates technical differentiation and product stickiness, aligning with a durable structural shift toward decentralized diagnostics if commercial adoption scales.
Consumables-led Business Model PotentialSelling consumables alongside instruments supports a recurring revenue model and higher lifetime customer value. If the company secures sufficient install base, consumables can provide predictable, margin-accretive revenue over time and improve cash generation durability versus one‑time instrument sales.
Equity Turned Positive On A TTM BasisA return to positive equity reduces immediate insolvency risk and can improve access to financing and partner confidence. While not a cure for operating losses, a positive equity position provides a modest structural cushion and better leverage for future capital raises or strategic partnerships.
Bears Say
Tiny, Declining Revenue BaseRevenue run‑rate is extremely low and falling, indicating weak commercial traction. Such a small base cannot support fixed R&D and commercial costs, making sustainable margin expansion unlikely without a material and sustained lift in sales or adoption of the platform.
Persistent Heavy Cash BurnLarge negative operating and free cash flows erode runway and force reliance on external financing. Persistent cash burn constrains the company's ability to invest in commercialization or scale production, increasing the long‑term risk that growth initiatives cannot be funded without dilution or costly debt.
High Leverage And Limited Balance‑sheet FlexibilityDebt materially exceeds equity, creating refinancing and covenant risk that can hamper strategic choices. High leverage amplifies survival risk if revenues remain low and reduces capacity to absorb further operating losses or invest in scaling the business without significant external support.
QLIFE FAQ
What was Qlife Holding AB’s price range in the past 12 months?
Qlife Holding AB lowest stock price was kr1.20 and its highest was kr5.70 in the past 12 months.
What is Qlife Holding AB’s market cap?
Qlife Holding AB’s market cap is kr57.75M.
When is Qlife Holding AB’s upcoming earnings report date?
Qlife Holding AB’s upcoming earnings report date is Aug 26, 2026 which is in 92 days.
How were Qlife Holding AB’s earnings last quarter?
Currently, no data Available
Is Qlife Holding AB overvalued?
According to Wall Street analysts Qlife Holding AB’s price is currently Overvalued.
Does Qlife Holding AB pay dividends?
Qlife Holding AB does not currently pay dividends.
What is Qlife Holding AB’s EPS estimate?
Qlife Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qlife Holding AB have?
Qlife Holding AB has 28,874,178 shares outstanding.
What happened to Qlife Holding AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Qlife Holding AB?
Currently, no hedge funds are holding shares in SE:QLIFE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Qlife Holding AB
Qlife Holding AB (QLIFE) is a biotechnology company based in Sweden, specializing in the development of advanced diagnostic tools aimed at improving patient care and health outcomes. The company focuses on innovative solutions in the healthcare sector, particularly in the areas of personalized medicine and point-of-care diagnostics. Qlife's core products include its proprietary diagnostic platforms, which utilize advanced technology to deliver rapid and accurate health assessments.